Search Results 551-560 of 17119 for monoclonal antibody
"Mayo Clinic has the clarity of vision to lead in this space. I'm grateful to be a part of it." ###. What's the latest on monoclonal antibody therapies to ...
... monoclonal antibody targeting MISIIR. Oncotarget. 2017 Oct 17; 8 (49):85214-85223 Epub 2017 July 27. View PubMed; Murphy BL, Glasgow AE, Keeney GL, Habermann ...
- Monoclonal antibodies, antibody-drug conjugates, or radioimmunoconjugates: 4 weeks (2 weeks with documented disease progression) - T-cell or other cell ...
His area of specialization was in the study of abzymes, a unique antibody subtype that expresses catalytic activity. ... monoclonal IgM antibodies in animal ...
When bone marrow produces an unusual protein in the blood, it can sometimes lead to certain types of blood cancer.
The FDA also has authorized the monoclonal antibody pemivibart (Pemgarda) to prevent COVID-19 in some people with weakened immune systems. People can take ...
Given that family members of CLL patients are known to have an increased risk of CLL (on the order of 8-fold), and they have a higher prevalence of MBL than in ...
Research. Researchers at Mayo Clinic coined the term monoclonal gammopathy of undetermined significance (MGUS). They have been studying the disorder for decades ...
Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the body's immune system attack the cancer and may interfere with the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.